TECH peers and competitors
Bio-Techne Corporation · end-of-day data as of Oct 16, 2026
Bio-Techne Corporation
$72.57+1.5%
Hold · 13 analystsPT $67.46 -7.0%
TECH’s peers by industry and size include Vertex Pharmaceuticals (VRTX), Moderna (MRNA) and Regeneron Pharmaceuticals (REGN). Among these 12 companies TECH ranks 8th by market cap ($11.38B); its P/E of 62.6 compares with a median of 19.8 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $499.74 | -1.8% | -10.4% | +14.0% | 29.1 | $127B | |
| 2 |  | $218.01 | -7.8% | -7.8% | -25.0% | — | $87.04B | |
| 3 |  | $790.74 | -0.7% | -7.2% | +8.7% | 19.6 | $81.41B | |
| 4 |  | $231.83 | -0.9% | -52.8% | +61.5% | 39.2 | $31.02B | |
| 5 |  | $113.07 | -0.2% | -13.0% | +13.6% | 14.4 | $22.92B | |
| 6 |  | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | |
| 7 |  | $187.31 | -1.0% | -22.3% | +24.2% | 16.5 | $11.95B | |
| 8 | | $72.57 | +0.1% | -0.1% | -7.0% | 62.6 | $11.38B | |
| 9 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B | |
| 10 |  | $185.10 | -1.2% | -23.9% | +11.1% | 7.6 | $10.91B | |
| 11 |  | $147.31 | -1.4% | -25.4% | +35.1% | 25.6 | $10.46B | |
| 12 |  | $141.10 | +1.7% | -59.3% | +32.3% | 26.4 | $9.79B |
Data as of Oct 16, 2026 close.